InvestorsHub Logo
Followers 829
Posts 119609
Boards Moderated 14
Alias Born 09/05/2002

Re: biotech_researcher post# 819

Friday, 01/09/2015 11:14:25 AM

Friday, January 09, 2015 11:14:25 AM

Post# of 2958
Good news and bad news in that arithmetic. Bad: The "0.4" fraction should be "0.3"—i.e. ENTA's royalties are based on 30% of ABBV's sales, which is the portion ascribed by agreement to ABT-450. Good: The 12% royalty rate (applied to the 30% of ABBV's sales) is the lowest tier; when sales exceed specified (undisclosed) thresholds, the 12% rate rises to as much as 20%.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News